Andrew Callos
Förmögenhet: 4 M $ per 2026-05-31
Förmögenhet: 4 M $ per 2026-05-31
Andrew M.
Callos is Chief Commercial Officer & Executive VP at Cytokinetics, Inc. since 2021.
Formerly, Mr. Callos was Vice President-US Cardiology & Metabolic Marketing at Pfizer Inc. and Assistant Vice President-Marketing at Wyeth Pharmaceuticals, Inc. Mr. Callos completed undergraduate education at Drexel University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-01 | 58 555 ( 0,05 % ) | 4 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Företagsledare/Principal | 2021-03-01 |
| Företag | Position | Slut |
|---|---|---|
| PFIZER INC. | Företagsledare/Principal | - |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Försäljning & Marknadsföring | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån